PowerShares Dynamic Biotech & Genome Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (26)

View All

Latest Posts

About This Stock More About This Stock
ETFs In Focus On Bayer's Bet On Gene Therapy
Article By: Sweta Killa
Thursday, October 29, 2020 11:58 PM EST
Merger and acquisition activities have heated up in recent months and the niche spaces are in the limelight. After the telemedicine industry, gene therapy stocks jumped on the bandwagon.
In this article: GNOM, PBE, ARKG, IDNA
Read
Profit From The Genomics Market Momentum With These ETFs
Article By: Zacks Investment Research
Saturday, May 23, 2020 7:04 PM EST
It appears that growing demand for personalized medicine, solid investments and higher R&D activities can make genomics the next big thing in the investing space. We highlight a host of ETFs that investors can keep tabs on.
In this article: GSK, GNOM, PBE, ARKG, IDNA
Read
The Landscape Of Biotech ETFs
Article By: Nancy Zhang
Tuesday, January 8, 2019 2:17 AM EST
The challenge is to create a quality biotech index with a rule-based system, so the picking and re-balancing are handy and quick.
In this article: IBB, PBE, BBC, CNCR
Read
Should You Invest In The Invesco Dynamic Biotechnology & Genome ETF (PBE)?
Article By: Sweta Killa
Thursday, November 22, 2018 1:05 PM EST
Investor-friendly, sector ETFs provide many options to gain low risk and diversified exposure to a broad group of companies in particular sectors.
In this article: PBE Also: IBB, AMGN, BIIB, VRTX, XBI
Read
M&A Waves Pushing Biotech ETFs Higher
Article By: Sweta Killa
Thursday, January 18, 2018 2:16 PM EST
The biotech corner of the broad healthcare sector is in the spotlight to start the New Year, as the new tax legislation has enticed U.S. companies to bring offshore cash back home, sparking waves of mergers and acquisitions.
In this article: FBT, PBE, BBC, CNCR Also: CELG, JUNO
Read
All Posts

Latest Tweets for $PBE

No tweets yet!